Cancer Research Cancer Epigenetics Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haq, R.
Right arrow Articles by Zanke, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haq, R.
Right arrow Articles by Zanke, B.
[Cancer Research 62, 5076-5082, September 1, 2002]
© 2002 American Association for Cancer Research

Molecular Biology and Genetics

Constitutive p38HOG Mitogen-activated Protein Kinase Activation Induces Permanent Cell Cycle Arrest and Senescence1

Rizwan Haq, James D. Brenton, Mark Takahashi, Dina Finan, Robert Rottapel and Brent Zanke2

Institute of Medical Science, University of Toronto [R. H., B. Z.]; Ontario Cancer Institute [R. H., J. D. B., M. T., D. F., R. R., B. Z.]; and Department of Medical Oncology and Hematology, Princess Margaret Hospital [J. D. B., B. Z.], Toronto M6G 2M2, Ontario, Canada


   ABSTRACT
Top
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cellular senescence, initially observed during subculturing of normal diploid fibroblasts, can also be induced by chronic exposure to cellular stress, such as UV light, oxidative stress, or DNA damaging agents. Here we demonstrate that stable expression of an activated form of MKK6 (MKK6EE), a direct activator of the stress-induced p38HOG mitogen-activated protein kinase pathway, is sufficient for inducing features of senescence including a flattened, vacuolated, and irregular morphology, staining for acidic ß-galactosidase, and accumulation of age-associated pigments. Consistent with the senescent phenotype, p38HOG activation induces a G1 cell cycle arrest, which is permanent and irreversible after 4 days. MKK6EE also induces biochemical features of senescence in a p38-dependent manner, including enhanced expression of p21CIP, a cyclin-dependent kinase inhibitor. Microarray analysis of MKK6EE cells showed a pattern of gene expression noted previously in Werner Syndrome and senescent fibroblasts. These results define p38HOG as an intracellular pathway that activates a senescence checkpoint in tumor cells and may play a role in Ras- or stress-induced senescence.


   INTRODUCTION
Top
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The capacity of normal human cells to divide in culture is limited. For example, in normal human fibroblasts, proliferation decreases and finally halts after only 50 population doublings (1) . This process of cellular ageing, called cellular senescence, contrasts to the high proliferative capacity of transformed, cancerous cells, which can be maintained in culture indefinitely (2) . Senescence is characterized by physiological, structural, biochemical, and molecular changes. Aged cells in culture are typically larger, flatter, irregular, vacuolated, and accumulate dense lysosomal bodies containing fluorescent pigments (3 , 4) . Senescent cells fail to respond to growth factors or mitogens, and are permanently and irreversibly arrested at the G1 or G2 phases of the cell cycle (reviewed in Ref. 5 ). Biochemically, they show evidence of oxidative stress with damaged DNA and accumulation of modified proteins (6 , 7) . This phenotype is characterized by the increased expression of several genes, including those encoding extracellular matrix proteins and cell cycle genes such as the cdk inhibitors p16 and p21WAF1/Cip1/SDI-1, and cyclins D and E (5 , 8) .

Cellular senescence, initially observed during subculturing of normal diploid fibroblasts, can also be induced by hyperactivation of mitogenic pathways (9) , chronic exposure to cellular stress, such as UV light, oxidative stress (10) , or DNA damaging agents (11) . This "premature" senescence is indistinguishable from cellular senescence induced by serial passaging of human cells, suggesting that cellular senescence represents a fate choice influenced by extracellular and intracellular signal transduction pathways.

Although it is clear that some extracellular signals can induce premature senescence, the molecular pathways involved in these responses are largely unknown. The MAPKs3 are key signal transduction pathways that couple extracellular signals to changes in gene expression. At least five different MAPK pathways have been identified, which respond to distinct environmental signals having various substrate specificities mediating separate physiological effects. The prototypical MAPK pathway, ERK1/2, is activated by growth factors, hematological cytokines, and neurotrophins. In contrast, two MAPK pathways, the SAPKs, also known as the JNKs, and the p38HOG kinases, are poorly activated by most growth factors but respond to multiple cytotoxic stresses, including UV irradiation, chemotherapy, heat shock, and inflammatory cytokines. As many of the stresses that activate SAPKs and p38HOG kinases can also induce premature senescence, we have examined their role in this process. To address their role in senescence specifically, we selectively activated p38HOG or SAPK in U2OS cells. We find that activation of p38HOG, but not SAPK, induces profound growth inhibition, and morphological, biochemical, and genetic features of senescence.


   MATERIALS AND METHODS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Reagents.
The wild-type and kinase-dead (KA) human MKK6b cDNAs were kindly provided by Denis Templeton (Case Western Reserve University, Cleveland, OH). Dominant-positive MKK6EE was generated by substituting the acidic residue glutamic acid for each of Ser-207 and Thr-211, and adding an in-frame FLAG epitope to the 5' end using the Pfu polymerase (Stratagene) and PCR. SpeI/NotI-digested pCR-MKK6EE or pCR-MKK6KA cDNAs were subcloned into SpeI/NotI-digested pIRESpuro2 (denoted IRESp; Clontech). Murine wild-type MKK7 was obtained from Joeseph Penninger (Amgen Institute, Toronto, Ontario, Canada). To generate dominant-positive MKK7EE, Ser-275 and Thr-277 were each mutated to Glu by PCR mutagenesis (12) . FLAG-tagged SAPK{alpha} (JNK2), SAPKß (JNK3), and SAPK{gamma} (JNK1) were obtained from J. Woodgett (Ontario Cancer Institute). dn-cdk2 (pCMV-cdk2) was a kind gift of E. Harlow (Massachusetts General Hospital, Charleston, MA). Cdk2dn IRESpuro2 was obtained by subcloning the BamHI insert of pCMVcdk2 into pIRESpuro2. Gal4 fusions of ATF2, c-jun, and Elk1, and plasmids coding MEKEE, MEKK1{Delta}, and the GAL4 promoter were from the PathDetect system (Stratagene). pSV-ßgal was obtained from Promega. All of the plasmids were purified using the Qiagen Endo-Free kit, and sequences were verified. SB202190 was obtained from Calbiochem and used at 10-µM concentration. Fresh SB202190 and medium were added to cultured cells each day during long-term experiments.

Transfections and Western Blotting.
U2OS cells were obtained from American Type Culture Collection (Manassas, VA). All of the cells were grown in DMEM supplemented with FCS (10%; Life Technologies, Inc.), and antibiotics. U2OS cells were transfected using Fugene-6 reagent, as described by the manufacturer (Roche). Where appropriate, cells were selected in puromycin (3 µg/µl) 2 days after transfection. In all of the transfections, a constant amount of DNA was used including the appropriate empty vector.

Cell extracts were prepared using NP40 lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.5% NP40, 5 mM NaF, 0.5 mM Na3VO4, 1 µg/ml aprotinin, and 1 µg/ml leupeptin]. After incubation on ice (30 min), lysates were cleared by centrifugation at 10,000 x g. Protein content of lysates was normalized by the Bradford method (Bio-Rad). For Western blotting, equal amounts of protein were separated by SDS-PAGE and blotted on Immobilon-P (Millipore), and incubated with antibodies as indicated. Antibodies to the following molecules were used: phospho-p38HOG (NEB), p38HOG (Santa Cruz), FLAG M2 (Sigma), {alpha}-tubulin (Sigma), p21 (Santa Cruz), cyclin E (HE12; BD PharMingen), cyclin D (DCS-6; BioMol), p53 (clone 1801; provided by S. Benchimol, Ontario Cancer Institute), cyclin A (Santa Cruz), and pRb (14001A, BD PharMingen).

Colony Formation and Growth Curves.
Colony formation assays have been used to demonstrate senescence-like effects induced by the retinoblastoma protein (13) . We used a modified protocol to assess the effect of p38 on senescence. Cells (3 x 105) were plated in 100-mm dishes, transfected with the indicated plasmid, and selected as described above. For coactivation of p38 and SAPK, we transfected MKK6EE, MKK7EE, and SAPK{gamma} in a 1:3:3 molar ratio. Two weeks later, cells were stained with 50% methanol and 1.5% crystal violet. Colonies were defined as >20 cells. Single viable cells were also counted as indicated. Parallel plates were transfected and selected for analysis of expression and activation of individual MAPKs.

To measure cell growth, antibiotic selected cells were trypsinized and replated in 24-well dishes (1 x 104 cells/well). At the indicated times, cells were washed twice with PBS, fixed in 10% formaldehyde for 10 min, and rinsed with distilled water. Cells were stained with 0.1% crystal violet for 30 min, rinsed extensively, and allowed to dry. Dye was extracted from cells in each well with 10% acetic acid (200 µl) for 30 min. Absorbance at 595 nm was measured in 96-well microtiter plates in triplicate.

SA-ßgal activity was determined using the standard protocol (3 , 14) . As a positive control, BJ fibroblasts were serially subcultured until senescent (population doubling ~85). BJ cells expressing the telomerase subunit (BJ/TERT) were a kind gift of Homayoun Varizi (Whitehead Institute, Boston, MA).

Luciferase Assays.
Luciferase and ß-galactosidase assays were performed in triplicate using the Dual-Light system (Tropix, Foster City, CA) with protocols recommended by the manufacturer. Luciferase values were normalized for transfection efficiency by ß-galactosidase readings. Results are expressed as averages of normalized values for at least three replicates.

Flow Cytometry.
Puromycin-selected cells were pulsed for 2 h with BrdUrd (10 µM; Sigma) before trypsinization, washing, and resuspension in PBS. Cells were permeabilized and fixed using the BrdUrd fluorescence-activated cell sorter kit (Becton Dickinson). Flow cytometry was done using a Becton-Dickinson FACScan or FACScalibur, using 488-nm excitation, and the FL1 (BrdUrd) and FL3 (PI) filters. At least 10,000 cells were analyzed per sample.

To detect autofluorescence associated with lipofuscin accumulation, puromycin-selected cells were trypsinized, washed, and examined using 488-nm excitation and the FL1 filters as described (15) .

Stress-induced Senescence.
U2OS cells were plated in six-well plate at a density of 1 x 106 cells/well. Wells containing 10 µM of SB202190 or vehicle control were treated with 150 µM H2O2 or irradiated at 10 Gy. After 2 h, peroxide was removed, and cells were washed in PBS and recultured in fresh medium. SB202190 was replaced every day. After 7 days, cells were stained for SA-ßgal. For the {gamma}-ray experiment, both mock and irradiated were incubated for 11 days. Cells were then stained for SA-ßgal activity as above.

Northern Blotting and Microarray Analysis.
Total RNA was extracted using the RNeasy mini kit (Qiagen) after 6 days of puromycin selection. Denatured RNA was resolved on 1.2% agarose-formaldehyde gels, transferred to Hybond nylon membranes (Amersham) and cross-linked using a Stratalinker (Stratagene). Probes were generated from p21 or 36B4 cDNA templates using the Random Priming kit (Amersham).

For microarray analysis total RNA (10 µg) was labeled by reverse transcription in the presence of Cy3- or Cy5-dCTP (Amersham Pharmacia) and 6.67 mM of dATP, dGTP, dTTP, as described previously (16) . Microarrays containing 19,200 duplicated cDNA probes were obtained from the Ontario Microarray Consortium. Averaging of duplicate spots and arrays was performed using the Array-Analysis software4 with a cutoff signal:noise ratio and a minimum intensity threshold of 2.0 SDs above mean background for both channels.


   RESULTS
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Specific Activation of p38 by MKK6EE in U2OS Cells.
Phosphorylation of MAPKs at invariant tyrosine and threonine residues by dual specificity kinases is necessary and sufficient for their activation. Two such kinases, MKK6 and MKK3, specifically phosphorylate the p38HOG MAPKs but not ERK or SAPK (17) . Overexpression of MKK6EE, a constitutively active version of MKK6, induces p38HOG phosphorylation in the absence of additional stimulation (17) .

To confirm the specificity of MKK6EE we examined the activation of several MAPK-pathway responsive transactivating domains. The transactivation domains of ATF2, Elk-1, and c-Jun are physiologically phosphorylated by p38HOG, ERK, and SAPK, respectively. Phosphorylated transactivation domains, when expressed as fusions with the GAL4 DNA-binding domain, activate a coexpressed promoter containing five GAL4 DNA-binding sites upstream of the luciferase gene. As expected, expression of MKK6EE in U2OS cells increased the activity of GAL4-ATF2 ~4.5-fold, whereas kinase-dead MKK6 slightly reduced basal activity (Fig. 1)Citation . Addition of SB202190, a specific p38{alpha}/ß inhibitor reduced the effect of MKK6EE to near basal levels (Fig. 1)Citation but did not affect expression of MKK6EE (data not shown). MKK6EE had no significant effect on either the ERK-responsive GAL4-Elk1 or SAPK-responsive GAL4-cJun chimeric transcription factors, although expression of control MEKEE or MEKK1 constructs activated ERK- and SAPK-responsive elements, respectively (Fig. 1)Citation . These results confirm the specificity of MKK6EE for p38HOG-induced transcription in U2OS cells.



View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 1. MKK6EE specifically induces p38-dependent gene expression. Activation of the GAL4-responsive reporters by chimeric transcription factors was determined in U2OS cells transfected with the indicated plasmids. Data (three replicates) is normalized to vector alone and for transfection efficiency; bars, ±SD.

 
Loss of Proliferation in Tumor Cells Expressing Activated p38HOG.
Oxidative stress is associated with aging of many cell types and mediates premature cellular senescence (18 , 19) . As p38HOG is activated by oxidative stress, we examined whether its activation was sufficient to induce a senescent phenotype. First, to test its effect on growth, we coexpressed MKK6EE or a kinase-dead mutant with the puromycin resistance gene using a single promoter system, which separates two open reading frames with an internal ribosome entry site (Fig. 2A)Citation . Use of this construct causes virtually all of the antibiotic-resistant transfected cells to express the gene of interest (20) .



View larger version (44K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 2. p38HOG activation inhibits cell proliferation. Methylene-blue stained colonies of U2OS cells (>=20 cells; A and B) or single cells (B) were counted 2 weeks after transfection with the indicated plasmids and normalized to vector control (A). Inset, MKK7EE induces phosphorylation of endogenous SAPK. Cells were transfected with the indicated plasmids along with 10 µM SB202190 or DMSO control (C). Photographs were taken at 2 weeks after transfection; bars, ±SD.

 
We examined the effect of expressing MKK6EE on the growth of U2OS cells, a well-studied osteogenic sarcoma cell line that retains both wild-type pRb and p53 (21 , 22) . Cells were transfected with pIRES MKK6EE or pIRES MKK6KA, and antibiotic-resistant colonies were counted after 2 weeks. Relative to cells transfected with empty vector alone or with MKK6KA, <6% of the MKK6EE-transfected cells formed colonies (Fig. 2)Citation . Incubation of cells with the p38-specific inhibitor SB202190 blocked the inhibitory effect of MKK6EE on cell proliferation (Fig. 2B)Citation .

Whereas MKK6EE-transfected cells did not result in proliferating colonies, many viable, non dividing, puromycin-resistant single cell clones were observed (Fig. 2C)Citation . These cells exhibited increased size and morphology, similar to that observed in senescent cells. MKK6EE-transfected cells remain adherent, flat, and enlarged for at least 3 weeks (data not shown). By contrast, expression of dn-cdk2 eliminated all of the viable cells illustrating that the cell cycle effects induced by MKK6EE are qualitatively different from those of interfering mutants of cdk2. This latter result may indicate that sustained dn-cdk2 expression induces apoptosis, as has been reported recently in U2OS cells (23) .

To examine the role of SAPK in cell proliferation, we made use of a constitutively active version of MKK7, a SAPK activator. Stable expression of MKK7EE alone (not shown) or in combination with SAPK{alpha}, SAPKß, or SAPK{gamma} isoforms increased colony formation in U2OS cells with demonstrated induction of SAPK phosphorylation (Fig. 2Citation , inset). Thus, constitutive activation of p38HOG and SAPK has different effects on cell proliferation. We also examined the effect of coactivation of p38 and SAPK. Even with 3-fold molar excess of SAPK components, sustained MKK6EE expression induced senescence in U2OS indicating that prolonged p38 activation is dominant over SAPK.

To examine the cell cycle effects of MKK6EE, kinase-dead MKK6, or vector control transfection, puromycin-selected cells were pulsed with BrdUrd, and analyzed for DNA content and BrdUrd incorporation. As shown in Fig. 3Citation , MKK6EE expression leads to a near complete loss of BrdUrd-positive cells, consistent with a G1/G0 cell cycle arrest. The effect was almost completely inhibited by pretreatment of cells with SB202190 (10 µM). Thus, constitutive MKK6EE expression inhibits cell proliferation through a mechanism requiring p38HOG{alpha}/ß activity.



View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 3. p38HOG induces G1 arrest. Propidium iodide/BrdUrd flow cytometry was performed in U2OS after 6 days of puromycin selection. The population in S phase is gated, and the percentage of cells in this gate is noted.

 
Cell Cycle Arrest Is Permanent and Irreversible.
As senescence is associated with permanent cell cycle arrest, we examined the reversibility of growth inhibition caused by MKK6EE. Puromycin-selected cells, transfected with pIRES MKK6EE, kinase dead MKK6, or vector, were plated, and cell growth was assayed over 9 days using a biomass assay. Compared with vector control, kinase-dead MKK6-expressing cells showed a slight but reproducible proliferative advantage (Fig. 4A)Citation . MKK6EE-expressing lines showed no increase in cell number over 9 days, suggesting a sustained effect on cell growth. This arrest was reversed by addition of SB202190 at the time of the transfection, but subsequent removal of the inhibitor at any time rapidly induced growth suppression (Fig. 4ACitation , Washout).



View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 4. Cell cycle arrest induced by p38HOG is permanent and irreversible. A, growth curves were determined for transfected and puromycin-selected cells. In SB+Washout, cells were transfected in the presence of SB202190, but the inhibitor was removed on day 0. B, cells were transfected with inhibitor added on or after transfection. After 8 days, cells were replated and growth curves examined as described in A. Each point is the mean of at least three replicates; bars, ± SD.

 
We next evaluated the minimal duration of p38HOG activation needed to produce a permanent cell cycle arrest. SB202190 was added to MKK6EE-expressing U2OS cells 0, 4, 6, or 8 days after transfection. At 8 days, cells were replated in 24-well dishes, and growth curves were examined over 7 additional days. Fig. 4BCitation shows that MKK6EE expression causes permanent cell cycle arrest if unopposed for at least 4 days. After 4 days, cell cycle arrest becomes independent of continuing p38HOG activation and is irreversible.

Cell Cycle Targets of p38HOG.
To characterize the mechanisms of p38HOG-induced cell cycle arrest, we examined expression of several cell-cycle regulatory proteins in MKK6EE-transfected cells by Western blotting. Lysates were prepared from puromycin-selected cells sampled 6 days after transfection. Declines in phosphorylated pRb and cyclin A observed in MKK6EE-expressing cells were consistent with a G1/S cell cycle arrest upstream of pRb (24) . Strikingly, a marked increase in p21Cip1, a cdk inhibitor, was observed although expression of p53 remained unchanged. Increased cyclin E and cyclin D were also noted, a pattern observed in senescent fibroblasts (25 , 26) .

p38 Activation Induces Features of Cellular Senescence.
Features of MKK6EE-expressing cells resemble those that have surpassed their proliferative capacity and have become senescent. Like MKK6EE-expressing cells, senescent cells have a flat, dendritic morphology, cease proliferation with G1 DNA content at subconfluent densities despite the presence of serum (reviewed in Ref. (5) , and arrest with G1 DNA content with increased cdk inhibitors (27, 28, 29) . Dimri et al. (3) reported that senescent cells have increased endogenous ß-galactosidase activity (SA-ßgal), which is not observed in terminally differentiated or quiescent cells. We observed that 40% of MKK6EE-expressing cells are strongly positive for SA-ßgal (Fig. 5A)Citation , consistent with a senescent phenotype. Cellular aging is also associated with lysosomal accumulation of the autofluorescent pigment, lipofuscin (4) . We examined the accumulation of lipofuscin-associated autofluorescence in vector, MKK6EE-, or MKK6KA-expressing cells. At 6 days after transfection there was a marked increase in fluorescence of MKK6EE-expressing cells compared with controls (Fig. 5B)Citation . This effect was not observed with MKK6KA cells or MKK6EE-expressing cells, which were treated with SB202190.



View larger version (45K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 5. MKK6EE induces morphological and histochemical features of premature senescence. A, U2OS cells were stained with SA-ßgal after 5 days selection in puromycin. The proportion of MKK6EE-expressing cells that stained positive was between 40 and 60%. As controls for staining normal, senescent human BJ fibroblasts or BJ fibroblasts, telomerase (TERT) were stained. B, autofluorescence of cells was examined 6 days after transfection. The percentage of cells within gate (M1) and the mean fluorescence intensities are noted for each sample.

 
MKK6EE Induces Gene Expression Consistent with Senescence.
Senescent cells have a characteristic pattern of gene expression characterized by changes in extracellular matrix genes, proinflammatory cytokines, and neutrophil genes (8) . To examine the effects of MKK6EE-induced gene expression we prepared RNA from MKK6EE or vector-transfected U2OS cells. cDNA prepared from the RNA was labeled with dCTP-conjugated Cy5 or Cy3 fluorescent dyes and hybridized to a microarray representing 19,200 known transcripts and expressed sequence tags. We identified 63 genes that were reproducibly activated or repressed by 1.75-fold or greater (see Supplemental Information; some genes were represented by more than one clone). Among major changes (Table 1)Citation , MKK6EE mRNA itself was induced 5.6-fold and p21 1.9-fold, consistent with our Western and Northern analysis (Fig. 4)Citation . Strikingly, many of the genes that we found to be up-regulated after MKK6EE expression have been identified in cells from Werner Syndrome subjects (30) . Specifically, we observed increases in the light chains of ferritin (4.8-fold), {alpha}B-crystallin (13-fold), extracellular matrix proteins, and neutrophil recruitment genes, which have been identified as senescence-associated genes (30, 31, 32) . Collectively, our analysis indicates that p38 induces senescence of U2OS tumor cells that is similar genetically and morphologically to replicative senescence.


View this table:
[in this window]
[in a new window]

  		Table 1 Changes in senescent markers in cells constitutively expressing MKK6EE

Most highly activated known genes identified using array-analysis software.

 
p38 Is Not Necessary for Stress-induced Senescence.
The induction of ferritin by MKK6EE suggested that oxidative stress may share pathways with p38-induced senescence. Iron potentiates the generation of reactive hydroxyl species and leads to oxidative damage of proteins and lipids (33) . As hydrogen peroxide and related oxidative damage also leads to senescence, we examined the requirement of p38 in this process. Treatment of U2OS cells with hydrogen peroxide lead to a dose-dependent accumulation of senescent cells, as identified by SA-ßgal staining. Although peroxide activated p38, pretreatment with SB202190 did not block senescent morphology or SA-ßgal staining (Fig. 7)Citation . We also examined the role of p38 in {gamma}-irradiation and transforming growth factor ß-induced (data not shown) senescence. Senescence induced by these agents also did not require p38 activity in U2OS cells (see Fig. 7Citation ; data not shown). Together, these results indicate that p38 is sufficient but not necessary for stress-induced senescence, suggesting a role for additional, parallel stress-induced senescence pathways.



View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 7. p38 is not required for stress-induced senescence. U2OS cells were treated with the indicated stress (see "Materials and Methods") in the presence of SB202190 or vehicle control. SA-ßgal was determined after 7 days (peroxide) or 11 days (irradiation). Results represent averages of at least three independent experiments; bars, ±SD.

 

   DISCUSSION
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
We demonstrate that expression of activated MKK6 induces morphological, biochemical, and genetic markers of cellular senescence, including permanent cell cycle arrest, up-regulation of p21Cip1, SA-ßgal staining, and lipofuscin-associated autofluorescence. Senescence induced by expression of MKK6EE was blocked by the specific p38 inhibitor, SB202190, and was not observed on overexpression of a kinase-dead MKK6 gene, indicating that our results are not because of a nonspecific response to overexpression or because of nonspecific effects of the inhibitor. As SB202190 is unable to inhibit p38{delta} or p38{gamma}, the senescence program induced by activated MKK6 is dependent on p38{alpha} and/or p38ß. Both of these isoforms are expressed in U2OS cells (34) .

Interestingly, p38-dependent cell cycle arrest was irreversible after 4 days of MKK6EE expression, indicating that p38 induces a time-dependent physiological response. The basis for this delayed commitment is unclear. However, the duration and strength of MAPK signals is a determinant in their physiological effects in other contexts. For example, transient ERK activation leads to cell proliferation, whereas robust, sustained activity leads to terminal differentiation or senescence (9 , 35, 36, 37) . Similarly, transient SAPK activity is associated with proliferation, whereas extended activity may play a role in apoptosis (38) .

The molecular effectors of p38-dependent senescence remain to be understood. Senescence induced by ERK pathway components in murine cells requires the cdk inhibitor p21Cip1 and p19ARF (9 , 36 , 37) , and may also be dependent on p53 in some cases. In our experiments, MKK6EE induced p21 mRNA and protein, but U2OS cells do not express p16 or p19. Furthermore, p53 levels were not increased, and it appears not to be required for p38-dependent cell cycle arrest (data not shown). The retinoblastoma protein may be critical, as it is involved in senescence-associated expression of fibronectin and osteonectin, genes that are also up-regulated by MKK6EE (39) .

The relationship between p38- and ERK-induced senescence also remains to be explored. Morooka and Nishida (40) have demonstrated that expression of MEK results in p38 activation and neurite outgrowth, which is blocked by SB23580. These surprising results indicate an essential role for p38 in ERK-mediated physiological effects. However, we have not been able to observe any activation of p38 by activated MEK in U2OS cells, and expression of MKK6EE appears to inhibit, not increase, the activity of ERK (data not shown).

Telomerase may also be a central regulator of senescence because expression of its catalytic subunit is sufficient to extend the life of human cells in vitro (41 , 42) . Von Zgliniki (43) reported an accelerated rate of telomere shortening in fibroblasts exposed to hyperoxia, indicating that telomerase can be modified by extracellular stress signals.

To relate the effects of MKK6EE expression to senescence at the molecular level, we examined global gene expression by microarray analysis. The results of this analysis demonstrated considerable similarity of gene expression of MKK6EE-expressing cells and senescent fibroblasts. The most highly induced genes includes fibronectin, an essential extracellular matrix component that is overexpressed in senescent pig or human fibroblasts (30 , 44, 45, 46) . Collagen and osteonectin, which are up-regulated by MKK6EE, are also induced in cells from patients with Werner Syndrome and in late passage fibroblasts (30 , 44 , 47) . Collagenase is also differentially expressed in MKK6EE-expressing cells and in other models of senescence suggesting that extracellular matrix can change growth potential and may contribute to the appearance of these cells (48 , 49) . Osteonectin, which is also up-regulated by MKK6EE, can inhibit cell cycle progression, although its relation to p38HOG-induced G1 arrest remains to be defined (50) .

Previous reports have implicated cellular stress in senescence in both normal (39) and immortalized cell types (11 , 51) . Exposure of fibroblasts to hydrogen peroxide induces irreversible growth arrest and morphological changes resembling senescence (10) . Wang et al. (51) reported that treatment of nasopharyngeal-transformed cells with cis-platinum induces senescence. As p38 is activated by these and other stresses, it may be a mediator of such stress-induced senescence. p38 may also play a role in senescence induced by repeated passaging, as senescent skeletal muscle demonstrates hallmarks of a stress responses, including expression of known p38 targets, such as MAPKAPK-2 (31) .

Our results suggest that cellular senescence represents a fate decision that can be modified by intracellular signal transduction pathways. As we were able to induce senescence in tumor cells, genetic changes that have occurred in U2OS cells are apparently not sufficient to prevent p38HOG-induced senescence. We suggest that sustained activation of p38 in cancer cells may provide a novel therapeutic approach. Conversely, use of specific p38HOG inhibitors may delay replicative senescence and aging.



View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
  		Fig. 6. Expression of cell cycle-regulated genes in stably transfected cells. Protein (A) or RNA (B) was extracted from U2OS cells expressing empty vector or MKK6. SB202190 was added at time of transfection and maintained the duration of the experiment. Samples were subjected to Western or Northern blotting.

 

   ACKNOWLEDGMENTS
 
We thank Barbara Iafrate (Ontario Cancer Institute, Toronto), James Woodgett (Ontario Cancer Institute, Toronto), Dennis Templeton (Case Western Reserve, Cleveland, OH, and Henry Klamut (Ontario Cancer Institute, Toronto) for reagents and advice.


   FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 R. H. is supported by a Canadian Institutes of Health Research (CIHR) MD/Ph.D. studentship. J. D. B was additionally supported by a Pathological Society of Great Britain and Ireland Fellowship. B. W. Z. is supported by Grants from CIHR and the Leukemia Research Foundation of Canada. Back

2 To whom requests for reprints should be addressed, at The Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada, T6G 1Z2. Email: zanke{at}cancerboard.ab.ca Back

3 The abbreviations used are: MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; SAPK, stress-activated protein kinase; JNK, c-Jun NH2-terminal kinase; pRB, protein retinoblastoma; BrdUrd, bromodeoxyuridine; dn-cdk2, dominant-negative cyclin-dependent kinase 2; cdk, cyclin-dependent kinase; SA-ßgal, senescence-associated ß-gal; MEK, mitogen-activated protein/extracellular signal-regulated kinase kinase. Back

4 Internet address: http://dna.sourceforge.net. Back

Received 4/ 3/01. Accepted 7/ 3/02.


   REFERENCES
Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res., 37: 614-636, 1965.[Medline]
  2. Smith J. R., Pereira-Smith O. M. Replicative senescence: implications for in vivo aging and tumor suppression. Science (Wash. DC), 273: 63-67, 1996.[Abstract]
  3. Dimri G. P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E. E., Linskens M., Rubelj I., Pereira-Smith O., et al A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.[Abstract/Free Full Text]
  4. Terman A., Brunk U. T. Lipofuscin: mechanisms of formation and increase with age. APMIS, 106: 265-276, 1998.[Medline]
  5. Stein G. H., Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays, 17: 537-543, 1995.[Medline]
  6. Chen Q., Fischer A., Reagan J. D., Yan L. J., Ames B. N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. USA, 92: 4337-4341, 1995.[Abstract/Free Full Text]
  7. Youngman L. D., Park J. Y., Ames B. N. Protein oxidation associated with aging is reduced by dietary restriction of protein or calories(Published erratum appears in Proc. Natl. Acad. Sci. USA, 89: 11107, 1992). Proc. Natl. Acad. Sci. USA, 89: 9112-9116, 1992.[Abstract/Free Full Text]
  8. Shelton D. N., Chang E., Whittier P. S., Choi D., Funk W. D. Microarray analysis of replicative senescence. Curr. Biol., 9: 939-945, 1999.[Medline]
  9. Serrano M., Lin A. W., McCurrach M. E., Beach D., Lowe S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88: 593-602, 1997.[Medline]
  10. Chen Q., Ames B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA, 91: 4130-4134, 1994.[Abstract/Free Full Text]
  11. Chang B. D., Broude E. V., Dokmanovic M., Zhu H., Ruth A., Xuan Y., Kandel E. S., Lausch E., Christov K., Roninson I. B. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res., 59: 3761-3767, 1999.[Abstract/Free Full Text]
  12. Zanke B. W., Boudreau K., Rubie E., Winnett E., Tibbles L. A., Zon L., Kyriakis J., Liu F. F., Woodgett J. R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum. UV irradiation or heat. Curr, Biol., 6: 606-613, 1996.[Medline]
  13. Templeton D. J., Park S. H., Lanier L., Weinberg R. A. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA, 88: 3033-3037, 1991.[Abstract/Free Full Text]
  14. Palmero I., Serrano M. Induction of senescence by oncogenic Ras. Methods Enzymol., 333: 247-256, 2001.[Medline]
  15. Goodwin E. C., Yang E., Lee C. J., Lee H. W., DiMaio D., Hwang E. S. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA, 97: 10978-10983, 2000.[Abstract/Free Full Text]
  16. DeRisi J. L., Iyer V. R., Brown P. O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (Wash. DC), 278: 680-686, 1997.[Abstract/Free Full Text]
  17. Raingeaud J., Whitmarsh A. J., Barrett T., Derijard B., Davis R. J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol., 16: 1247-1255, 1996.[Abstract]
  18. Melov S., Ravenscroft J., Malik S., Gill M. S., Walker D. W., Clayton P. E., Wallace D. C., Malfroy B., Doctrow S. R., Lithgow G. J. Extension of life-span with superoxide dismutase/catalase mimetics. Science (Wash. DC), 289: 1567-1569, 2000.[Abstract/Free Full Text]
  19. Shigenaga M. K., Hagen T. M., Ames B. N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA, 91: 10771-10778, 1994.[Abstract/Free Full Text]
  20. Rees, S., Coote, J., Stables, J., Goodson, S., Harris, S., and Lee, M. G. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein, Biotechniques, 20: 102–104, 106: 108–110, 1996.
  21. Lee W. H., Shew J. Y., Hong F. D., Sery T. W., Donoso L. A., Young L. J., Bookstein R., Lee E. Y. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (Lond.), 329: 642-645, 1987.[Medline]
  22. Diller L., Kassel J., Nelson C. E., Gryka M. A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S. J., Vogelstein B., et al p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.[Abstract/Free Full Text]
  23. Hu B., Mitra J., van den Heuvel S., Enders G. H. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell. Biol., 21: 2755-2766, 2001.[Abstract/Free Full Text]
  24. Knudsen K. E., Weber E., Arden K. C., Cavenee W. K., Feramisco J. R., Knuden E. S. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death. Oncogene, 18: 5239-5245, 1999.[Medline]
  25. Dulic V., Drullinger L. F., Lees E., Reed S. I., Stein G. H. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA, 90: 11034-11038, 1993.[Abstract/Free Full Text]
  26. Lucibello F. C., Sewing A., Brusselbach S., Burger C., Muller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J. Cell Sci., 105: 123-133, 1993.[Abstract]
  27. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M., Smith J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.[Medline]
  28. Alcorta D. A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J. C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.[Abstract/Free Full Text]
  29. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.[Abstract]
  30. Murano S., Thweatt R., Shmookler Reis R. J., Jones R. A., Moerman E. J., Goldstein S. Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence. Mol. Cell. Biol., 11: 3905-3914, 1991.[Abstract/Free Full Text]
  31. Lee C. K., Klopp R. G., Weindruch R., Prolla T. A. Gene expression profile of aging and its retardation by caloric restriction. Science (Wash. DC), 285: 1390-1393, 1999.[Abstract/Free Full Text]
  32. Sottile J., Hoyle M., Millis A. J. Differential response of early and late passage fibroblasts to collagenase stimulatory factor in conditioned media. Coll. Relat. Res., 8: 361-374, 1988.[Medline]
  33. Halliwell B., Gutteridge J. M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol., 186: 1-85, 1990.[Medline]
  34. Wang X., McGowan C. H., Zhao M., He L., Downey J. S., Fearns C., Wang Y., Huang S., Han J. Involvement of the MKK6–p38{gamma} cascade in {gamma}-radiation-induced cell cycle arrest. Mol. Cell. Biol., 20: 4543-4552, 2000.[Abstract/Free Full Text]
  35. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77: 841-852, 1994.[Medline]
  36. Lin A. W., Barradas M., Stone J. C., van Aelst L., Serrano M., Lowe S. W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev., 12: 3008-3019, 1998.[Abstract/Free Full Text]
  37. Zhu J., Woods D., McMahon M., Bishop J. M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev., 12: 2997-3007, 1998.[Abstract/Free Full Text]
  38. Chen Y-R., Wang X., Templeton D., Davis R. J., Tan T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and {gamma} radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271: 31929-31936, 1996.[Abstract/Free Full Text]
  39. Dumont P., Burton M., Chen Q. M., Gonos E. S., Frippiat C., Mazarati J. B., Eliaers F., Remacle J., Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic. Biol. Med., 28: 361-373, 2000.[Medline]
  40. Morooka T., Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J. Biol. Chem., 273: 24285-24288, 1998.[Abstract/Free Full Text]
  41. Vaziri H., Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol., 8: 279-282, 1998.[Medline]
  42. Bodnar A. G., Ouellette M., Frolkis M., Holt S. E., Chiu C. P., Morin G. B., Harley C. B., Shay J. W., Lichtsteiner S., Wright W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Wash. DC), 279: 349-352, 1998.[Abstract/Free Full Text]
  43. von Zglinicki T., Saretzki G., Docke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res., 220: 186-193, 1995.[Medline]
  44. Lecka-Czernik B., Moerman E. J., Jones R. A., Goldstein S. Identification of gene sequences overexpressed in senescent and Werner syndrome human fibroblasts. Exp. Gerontol., 31: 159-174, 1996.[Medline]
  45. Martin M., el Nabout R., Lafuma C., Crechet F., Remy J. Fibronectin and collagen gene expression during in vitro aging of pig skin fibroblasts. Exp. Cell Res., 191: 8-13, 1990.[Medline]
  46. Kumazaki T., Kobayashi M., Mitsui Y. Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exp. Cell Res., 205: 396-402, 1993.[Medline]
  47. Linskens M. H., Feng J., Andrews W. H., Enlow B. E., Saati S. M., Tonkin L. A., Funk W. D., Villeponteau B. Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucleic Acids Res., 23: 3244-3251, 1995.[Abstract/Free Full Text]
  48. West M. D., Pereira-Smith O. M., Smith J. R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res., 184: 138-147, 1989.[Medline]
  49. Sottile J., Mann D. M., Diemer V., Millis A. J. Regulation of collagenase and collagenase mRNA production in early- and late-passage human diploid fibroblasts. J. Cell Physiol., 138: 281-290, 1989.[Medline]
  50. Funk S. E., Sage E. H. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA, 88: 2648-2652, 1991.[Abstract/Free Full Text]
  51. Wang X., Wong S. C., Pan J., Tsao S. W., Fung K. H., Kwong D. L., Sham J. S., Nicholls J. M. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Res., 58: 5019-5022, 1998.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
A. K. Linnemann and S. A. Krawetz
Silencing by nuclear matrix attachment distinguishes cell-type specificity: association with increased proliferation capacity
Nucleic Acids Res., May 1, 2009; 37(9): 2779 - 2788.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Kwong, L. Hong, R. Liao, Q. Deng, J. Han, and P. Sun
p38{alpha} and p38{gamma} Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
J. Biol. Chem., April 24, 2009; 284(17): 11237 - 11246.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Abrahams, S. Mowla, M. I. Parker, C. R. Goding, and S. Prince
UV-mediated Regulation of the Anti-senescence Factor Tbx2
J. Biol. Chem., January 25, 2008; 283(4): 2223 - 2230.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Riuzzi, G. Sorci, and R. Donato
RAGE Expression in Rhabdomyosarcoma Cells Results in Myogenic Differentiation and Reduced Proliferation, Migration, Invasiveness, and Tumor Growth
Am. J. Pathol., September 1, 2007; 171(3): 947 - 961.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
X. Zhang, J. Kim, R. Ruthazer, M. A. McDevitt, D. E. Wazer, K. E. Paulson, and A. S. Yee
The HBP1 Transcriptional Repressor Participates in RAS-Induced Premature Senescence
Mol. Cell. Biol., November 15, 2006; 26(22): 8252 - 8266.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
V. Probin, Y. Wang, A. Bai, and D. Zhou
Busulfan Selectively Induces Cellular Senescence but Not Apoptosis in WI38 Fibroblasts via a p53-Independent but Extracellular Signal-Regulated Kinase-p38 Mitogen-Activated Protein Kinase-Dependent Mechanism
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 551 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
T. Davis, D. M. Baird, M. F. Haughton, C. J. Jones, and D. Kipling
Prevention of Accelerated Cell Aging in Werner Syndrome Using a p38 Mitogen-Activated Protein Kinase Inhibitor
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1386 - 1393.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. Beyne-Rauzy, N. Prade-Houdellier, C. Demur, C. Recher, J. Ayel, G. Laurent, and V. Mansat-De Mas
Tumor necrosis factor-{alpha} inhibits hTERT gene expression in human myeloid normal and leukemic cells
Blood, November 1, 2005; 106(9): 3200 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. P. Kim, X. Wang, A. Nakao, S. I. Kim, N. Murase, M. E. Choi, S. W. Ryter, and A. M. K. Choi
Caveolin-1 expression by means of p38{beta} mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide
PNAS, August 9, 2005; 102(32): 11319 - 11324.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Kaur, X. Liu, O. Gjoerup, A. Zhang, X. Yuan, S. P. Balk, M. C. Schneider, and M. L. Lu
Activation of p21-activated Kinase 6 by MAP Kinase Kinase 6 and p38 MAP Kinase
J. Biol. Chem., February 4, 2005; 280(5): 3323 - 3330.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M.-S. Jung, D.-H. Jin, H.-D. Chae, S. Kang, S.-C. Kim, Y.-J. Bang, T.-S. Choi, K.-s. Choi, and D. Y. Shin
Bcl-xL and E1B-19K Proteins Inhibit p53-induced Irreversible Growth Arrest and Senescence by Preventing Reactive Oxygen Species-dependent p38 Activation
J. Biol. Chem., April 23, 2004; 279(17): 17765 - 17771.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
N. N. Gushwa, D. Hayashi, A. Kemper, B. Abram, J. E. Taylor, J. Upton, C. F. Tay, S. Fiedler, S. Pullen, L. P. Miller, et al.
Thermotolerant Guard Cell Protoplasts of Tree Tobacco Do Not Require Exogenous Hormones to Survive in Culture and Are Blocked from Reentering the Cell Cycle at the G1-to-S Transition
Plant Physiology, August 1, 2003; 132(4): 1925 - 1940.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. B. Roninson
Tumor Cell Senescence in Cancer Treatment
Cancer Res., June 1, 2003; 63(11): 2705 - 2715.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. A. Aguirre-Ghiso, Y. Estrada, D. Liu, and L. Ossowski
ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK
Cancer Res., April 1, 2003; 63(7): 1684 - 1695.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haq, R.
Right arrow Articles by Zanke, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haq, R.
Right arrow Articles by Zanke, B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online